Doxazosin Mesylate
- Product NDC
- 67253-383
- 11-digit product format
- 672530383
- Labeler code
- 67253
- Product ID
- 67253-383_2a486bcb-1296-455e-8b3c-78bf5b217936
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Doxazosin Mesylate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Par Pharmaceutical
- Application
- ANDA076161
- Marketing category
- ANDA
- Marketing start
- 2004-06-10
- Marketing end
- 2021-03-31
- Substance
- DOXAZOSIN MESYLATE
- Active strength
- 8 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 67253-383-10 | 67253038310 | 100 TABLET in 1 BOTTLE (67253-383-10) | 100 tablet | 2004-06-10 | 2021-03-31 | No | No | Current |
| 67253-383-11 | 67253038311 | 1000 TABLET in 1 BOTTLE (67253-383-11) | 1000 tablet | 2004-06-10 | 2021-03-31 | No | No | Current |